Filter Results :

Your search for Biosimilars returned 69 reports

Sort by


Global Biosimilars Industry Report 2015

21 Jul 2015  |  Published by:  QYResearch
The Global Biosimilars Industry Report 2015 is a professional and in-depth study on the current state of the Biosimilars industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biosimilars market analysis is...

$ 2,800.00

Read More

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Global Forecast to 2020

16 Jul 2015  |  Published by:  MarketsandMarkets
Report Description Various factors have contributed to the rise in demand for biopharmaceutical products such as biologics and biosimilars. Some of these factors include the rising pressure to reduce healthcare expenditure, growing demand for cost-effective alternatives, growing burden of c...

$ 4,650.00

Read More

Global Cancer Biosimilars Market Opportunity Outlook

23 Jun 2015  |  Published by:  KuicK Research
Cancer incidences are escalating tremendously across the globe due to which burgeoning pressure has been created on pharmaceutical companies to come forth with viable products. Moreover, presently available drugs for cancer treatment are known for their superior ph...

$ 1,800.00

Read More

Biosimilars - Regulatory Framework and Pipeline Analysis

01 Jun 2015  |  Published by:  GBI Research
SummaryBiosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will ...

$ 2,995.00

Read More

The Future of Biosimilars 2015

01 Jun 2015  |  Published by:  FirstWord
The Future of Biosimilars 2015 offers expert insight and opinion on the key issues facing the high risk, high reward biosimilars market: how the market is performing, where the market is headed and which key milestones are being monitored. Gain insights on the recent market events, the current ...

$ 2,100.00

Read More

Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars

18 May 2015  |  Published by:  Access China Management
Responding to strong desire of overseas and multinational pharmaceutical manufacturers and domestic pharmaceutical manufacturers to carry out research and development of biosimilar products, this is first time in history, Chinese pharmaceutical authorities, China Food and Drug Administration o...

$ 750.00

Read More

Biosimilars: US Payer Perspectives

01 Apr 2015  |  Published by:  FirstWord
Biosimilars: US Payer Perspectives pulls back the curtain on the US biologics market and provides detailed and actionable insights from 12 expert US payers from a range of different organisations, including Pharmacy Benefit Managers, Managed Care Organisations and Integrated Delivery Networks. In...

$ 2,100.00

Read More

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

01 Apr 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of A...

$ 1,423.81

Read More

The 2016-2021 World Outlook for Biosimilars

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for biosimilars across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of t...

$ 995.00

Read More

The 2016 Report on Biosimilars: World Market Segmentation by City

01 Apr 2015  |  Published by:  Icon Group International, Inc
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report cov...

$ 995.00

Read More

Competitor Analysis: EGF-R Antibodies 2015 - Biosuperiors and Biosimilars of Erbitux

28 Mar 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux provides a competitor evaluation in the field of recombinant antibodies targeting epithelial growth factor receptor (EGF-R) to treat solid tumors as of March 2015. Purchase of the downloa...

$ 273.81

Read More

Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab

25 Mar 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides a competitor evaluation in the field of recombinant antibodies targeting CD20 for treatment of B-cell mediated malignancies and rheumatoid arthritis as of March 2015. Purchase of...

$ 328.57

Read More

Competitor Analysis: TNF Antibodies 2015 - Biosimilars and Biosuperiors of Humira, Remicade and Enbrel

22 Mar 2015  |  Published by:  La Merie Business Intelligence
The present Competitive Intelligence report about TNF Antibodies 2015 – Biosimilars and Biosuperiors of Humira, Remicade and Enbrel provides a competitor evaluation in the field of recombinant antibodies targeting tumor necrosis factor (TNF) alpha or its receptor used to treat various inflamma...

$ 547.62

Read More

2015 Deep Research Report on Global Biologics and Biosimilars Industry

03 Mar 2015  |  Published by:  QYResearch
Summary  2015 Deep Research Report on Global Biologics and Biosimilars Industry is a professional and depth research report on Global Biologics and Biosimilars industry.  For overview analysis, the report introduces Biologics and Biosimilars basic information including definition, ...

$ 2,600.00

Read More

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

15 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides a competitor evaluation in the field of recombinant antibodies targeting Her2 for treatment of Her2 positive breast and gastric cancer as of February 2015. Purchase of the downl...

$ 328.57

Read More
Total 69 records.